top of page

Scientific materials on cannabinoids

Here you will find scientific materials, articles and publications related to hemp derived ingredients. They focus on application of cannabinoids in cosmetics, medicine and veterinary and their anti-inflammatory, analgesic and antiviral (e.g. in case of SARS-Cov-2) properties. These are only selected examples of articles, studies. There are more available and the amount of scientific research is constantly growing. We encourage you to do your own research if you have a deeper interest in specific cannabis related issues.

shutterstock_1296586384.png

Cosmetics and dermatology

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4151231/

 

Cannabinoids in dermatology: a scoping review (1)

https://www.ncbi.nlm.nih.gov/pubmed/30142706

Cannabinoids in dermatology: a scoping review (2)

https://escholarship.org/uc/item/7pn8c0sb

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/

The Therapeutic Potential of Cannabinoids in Dermatology

https://www.ncbi.nlm.nih.gov/pubmed/30517778

Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429381/

In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties

https://www.mdpi.com/1420-3049/27/2/491?fbclid=IwAR2X0_K5YfldE7KB4D3bwLTkp9Lwc_WkpAmkaJ3s0S7hA_yZUJABQJD198U

Medicine

Cannabis Use Is Associated With Increased Levels of Soluble gp130 in Schizophrenia but Not in Bipolar Disorder

https://pubmed.ncbi.nlm.nih.gov/32714224/

 

CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action
https://pubmed.ncbi.nlm.nih.gov/33964342/

The antimicrobial potential of cannabidiol
https://www.nature.com/articles/s42003-020-01530-y

Cannabinoids Block Cellular Entry of SARS-CoV-2 Virus and the Emerging Variants

https://pubmed.ncbi.nlm.nih.gov/35007072/

Cannabidiol Inhibits SARS-CoV-2 Virus Replication and Promotes the Host Innate Immune Response

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987002/

Cannabinoid Acids: medical benefits of THCa and CBDa
https://www.kalapa-clinic.com/en/cannabinoid-acids-thca-and-cbda/

Veterinary

Single-Dose Pharmacokinetics and Preliminary Safety Assessment with Use of CBD-Rich Hemp Nutraceutical in Healthy Dogs and Cats

https://pubmed.ncbi.nlm.nih.gov/31635105/

Randomized blinded controlled clinical trial to assess the effect of oral cannabidiol administration in addition to conventional antiepileptic treatment on seizure frequency in dogs with intractable idiopathic epilepsy

https://pubmed.ncbi.nlm.nih.gov/31067185/

A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain

https://pubmed.ncbi.nlm.nih.gov/32345916/

Feline cognitive dysfunction as a model for Alzheimer's disease in the research of CBD as a potential treatment-a narrative review

https://pubmed.ncbi.nlm.nih.gov/33526138/

Safety and tolerability of escalating cannabinoid doses in healthy cats

https://pubmed.ncbi.nlm.nih.gov/33769105/

bottom of page